Related Experiment Video
Updated: Jul 8, 2025
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
Invasive Neuromodulation Techniques for Treatment-Resistant Depression.
Peter Theiss1, Francesco G Pucci1, Konstantin V Slavin2,3
1Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL, USA.
Current Topics in Behavioral Neurosciences
|December 11, 2023
Summary
Neurostimulation devices offer insights into depression mechanisms. Personalized approaches are crucial for effective treatment, as current evidence for vagal nerve, deep brain, and cortical stimulation remains limited.
Area of Science:
- Neuroscience
- Psychiatry
- Neurosurgery
Background:
- Surgically implanted neurostimulation devices have been investigated for depression treatment for 30 years.
- These interventions, despite surgical risks, allow localized neural activity alteration studies.
- They serve as critical tools for testing mechanistic models of depression.
Purpose of the Study:
- To review proposed mechanisms of action for neurostimulation in depression.
- To evaluate the clinical efficacy evidence for specific neuromodulation techniques.
- To explore the role of neural network interactions in treatment response.
Main Methods:
- Review of existing literature on vagal nerve stimulation (VNS).
- Review of existing literature on deep brain stimulation (DBS).
- Review of existing literature on epidural cortical stimulation (ECS).
Main Results:
- Evidence for clinical efficacy is limited across all three modalities (VNS, DBS, ECS).
- Long-term follow-up studies indicate the significance of inter-regional neural interactions.
- Therapeutic response appears dependent on the interplay between different brain areas.
Conclusions:
- Neuromodulation for depression requires a deeper understanding of neural network dynamics.
- Personalized stimulation strategies are likely necessary for optimizing treatment outcomes.
- Further research is needed to refine efficacy and application of these devices.
Related Concept Videos
01:30Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
01:23Antidepressant Drugs: MAOIs and Other Agents
247
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
247
01:14Brain Imaging
234
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
234